All Type of News
Large hospitals waiting for the launch of the new obesity drug ‘Belviq’
The new obesity drug, ‘Belviq,’ has been exceptionally noticeable among doctors.
Belviq has attracted doctors as a new obesity drug, which would be first launched since the last obesity drug in 13 years. Shinhan Inve...
3 pharmaceutical companies were indicated by the many in the rebate ‘secret voting’
It is known that despite the trend of the pharmaceutical companies’ transparent ethical management, illegal business activities, such as rebates, have still been made.
The Korea Pharmaceutical Manufacturers Associati...
GemVax and Samsung Pharm has launched its pancreatic cancer vaccine in Korea for the first time in the world
The GemVax’s pancreatic cancer vaccine, Liavax(code name: GV1001), has been acquired the final sale approval from the Ministry of Food and Drug Safety.
Liavax, a pharmaceutical product approved for the 21st time as ...
Celltrion has acquired approvals for Remsima in 13 of the 22 South American countriesCelltrion announced on the 29th that Remsima has been approved to sell from Instituto Nacional de Higiene Rafael Rangel in Venezuela. Thus, Celltrion is now able to sell Remsima...
|
The top 10 sales pharmaceutical distribution companies occupy 49.7% of the entire market share
It is known that the top 10 domestic pharmaceutical distribution companies (groups) own the half of the entire distribution industry’s market share.
Sales of those top 10 companies (32 corporations) were estimated to...
The generic market of ‘celecoxib’ is heated up along with approvals of 45 products only in this year
The arthritis treatment ‘celecoxib’ generic market has attracted the industry.
According to the Ministry of Food and Drug Safety, 103 generic products of ‘celecoxib,’ whose patent will be expired on the coming 11th o...
Green Cross will build a manufacturing factory for cell therapy products, showing active movements in ChinaTargeting the rapidly growing Chinese market, Green Cross is going to build a manufacturing facility for cell therapy products.
Green Cross Holdings (CEO Byung-gun Lee) announc...
|
Multinational pharmaceutical companies return payments for drugs in 95 days, which are faster than what listed companies experience
It is known that multinational pharmaceutical companies branched in the Korean market take approximately 3 months to return payments of selling pharmaceutical products.
The time is faster than what domestic listed co...
The patent trial of Viagra is concluded to be the win of domestic pharmaceutical companies and the defeat of PfizerThe win of domestic pharmaceutical companies is finalized in the patent trial over the impotency drug, ‘Viagra.’
The original manufacturing company, Pfizer, lost the patent tri...
|
Expansion of the National Health Insurance benefits on chronic hepatitis type B and osteoporosis treatments from the coming 1st
Next month, the health insurance benefit of the tenofovir solo therapy will be applied to chronic hepatitis type B multiple drug resistance patients.
Moreover, osteoporosis treatments will be available with the healt...
